CERS Q4 2025 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q4 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$58M+13.7% YoY

Gross Profit

$30M51.5% margin

Operating Income

-$641,000-1.1% margin

Net Income

-$2M-3.8% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

+9.6%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$12M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$222M

Total Liabilities

$157M

Stockholders' Equity

$64M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$58M	$51M	+13.7%
Gross Profit	$30M	$27M	+8.6%
Operating Income	-$641,000	-$1M	+55.8%
Net Income	-$2M	-$3M	+13.4%

Revenue Segments

Product

$58M82%

Government Contract

$12M18%